71 related articles for article (PubMed ID: 9541183)
1. Report for the EASD-Bayer Travel Fellowship for Young Scientist 1997. European Association of the Study of Diabetes.
Jones SM
Diabetologia; 1998 Mar; 41(3):20. PubMed ID: 9541183
[No Abstract] [Full Text] [Related]
2. Report on an EFSD/Merck Travel Fellowship for Young Scientists. European Foundation for the Study of Diabetes. Glomerular enlargement in Type 1 and Type 2 diabetes.
White K
Diabetologia; 2000 Nov; 43(11):51-2. PubMed ID: 11126419
[No Abstract] [Full Text] [Related]
3. [Effects of temocapril on the prevention of early diabetic nephropathy in OLETF rat, an animal model for type 2 diabetes].
Masuda H
Hokkaido Igaku Zasshi; 2002 Sep; 77(5):419-28. PubMed ID: 12404757
[No Abstract] [Full Text] [Related]
4. Report on an EASD-Bayer Travel Fellowship for young scientists. European Association for the Study of Diabetes.
Delaney CA
Diabetologia; 1999 Mar; 42(3):15. PubMed ID: 10096799
[No Abstract] [Full Text] [Related]
5. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
6. Report on a 1999 EASD Travel Fellowship for Young Scientists. European Association for the Study of Diabetes.
Mittendorfer B
Diabetologia; 2000 Sep; 43(9):33-4. PubMed ID: 11043870
[No Abstract] [Full Text] [Related]
7. Report from a member awarded an EASD-Bayer Travel Fellowship for Young Scientists 1997.
Weyer C
Diabetologia; 1997 Dec; 40(12):suppl 45-6. PubMed ID: 9447941
[No Abstract] [Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
9. Report of a 1998 EASD-Bayer travel fellowship for Young scientists. Effect of oxidized LDL and glucose in tyrosine kinase receptors.
Portero-Otin M
Diabetologia; 1999 Aug; 42(8):37-8. PubMed ID: 10491771
[No Abstract] [Full Text] [Related]
10. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
Fujii W
Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
[No Abstract] [Full Text] [Related]
11. The role of the anterior pituitary in the pathogenesis of diabetic glomerulosclerosis.
Ireland JT; Patnaik BK; Duncan LJ
Proc R Soc Med; 1967 Feb; 60(2):145-8. PubMed ID: 6018837
[No Abstract] [Full Text] [Related]
12. Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?
Quaggin SE; Coffman TM
J Am Soc Nephrol; 2007 Feb; 18(2):364-6. PubMed ID: 17259594
[No Abstract] [Full Text] [Related]
13. Immunohistochemical studies in diabetic glomerulosclerosis.
Davies MJ; Woolf N; Carstairs KC
J Pathol Bacteriol; 1966 Oct; 92(2):441-5. PubMed ID: 4164453
[No Abstract] [Full Text] [Related]
14. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
White KE
Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of nitric oxide synthase in the diabetic rabbit kidney: potential relevance to the early pathogenesis of diabetic nephropathy.
Mumtaz FH; Dashwood MR; Khan MA; Thompson CS; Mikhailidis DP; Morgan RJ
Curr Med Res Opin; 2004 Jan; 20(1):1-6. PubMed ID: 14741064
[TBL] [Abstract][Full Text] [Related]
16. Rodent models of streptozotocin-induced diabetic nephropathy.
Tesch GH; Allen TJ
Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
[TBL] [Abstract][Full Text] [Related]
17. [Cause and prevention of diabetic nephrosis].
Niki Y
Nihon Rinsho; 1968 May; 26(5):1186-91. PubMed ID: 5749796
[No Abstract] [Full Text] [Related]
18. Anionic charge sites in the kidney: comparison of two diabetic rat models.
Ward-Cook KM; Mahan JD; Frenchko CE; Albright A; Chiasera JM; McAllister C
Ann Clin Lab Sci; 1999; 29(4):286-98. PubMed ID: 10528828
[TBL] [Abstract][Full Text] [Related]
19. A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
Nakagawa T; Segal M; Croker B; Johnson RJ
Nephrol Dial Transplant; 2007 Oct; 22(10):2775-7. PubMed ID: 17595179
[No Abstract] [Full Text] [Related]
20. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
